CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 266 filers reported holding CYTOKINETICS INC in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,240,600 | -41.9% | 130,000 | -37.3% | 1.01% | -53.6% |
| Q1 2023 | $7,301,925 | -36.3% | 207,500 | -17.0% | 2.19% | -45.1% |
| Q4 2022 | $11,455,000 | -10.1% | 250,000 | -4.9% | 3.98% | -24.3% |
| Q3 2022 | $12,742,000 | +7.2% | 263,000 | -13.1% | 5.26% | -1.8% |
| Q2 2022 | $11,885,000 | -20.6% | 302,500 | -25.6% | 5.36% | +15.3% |
| Q1 2022 | $14,963,000 | -43.4% | 406,500 | -29.9% | 4.65% | -17.1% |
| Q4 2021 | $26,436,000 | +27.5% | 580,000 | 0.0% | 5.61% | +44.8% |
| Q3 2021 | $20,729,000 | +80.6% | 580,000 | 0.0% | 3.87% | +103.1% |
| Q2 2021 | $11,478,000 | -14.9% | 580,000 | 0.0% | 1.91% | -3.8% |
| Q1 2021 | $13,491,000 | +11.4% | 580,000 | -0.5% | 1.98% | +25.3% |
| Q4 2020 | $12,111,000 | +167.9% | 582,800 | +179.1% | 1.58% | +79.0% |
| Q3 2020 | $4,521,000 | -36.7% | 208,800 | -31.1% | 0.88% | -38.7% |
| Q2 2020 | $7,143,000 | – | 303,050 | – | 1.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,106,989 | $14,159,000 | 2.50% |
| Healthcare Value Capital, LLC | 100,000 | $672,000 | 0.71% |
| First Light Asset Management, LLC | 218,792 | $1,470,000 | 0.69% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 435,202 | $2,925,000 | 0.67% |
| TFS CAPITAL LLC | 899,951 | $6,048,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 422,250 | $2,838,000 | 0.28% |
| ALGERT GLOBAL LLC | 73,181 | $492,000 | 0.27% |
| LANSDOWNE PARTNERS (UK) LLP | 2,321,865 | $15,603,000 | 0.13% |
| Leisure Capital Management | 17,567 | $118,000 | 0.12% |
| Rotella Capital Management, Inc. | 15,778 | $106,000 | 0.09% |